JBBS  Vol.1 No.4 , November 2011
Neurocysticercosis Association with Cognitive and Aberrant Behavioural Symptoms: A Case Report and Review
ABSTRACT
Neurocysticercosis (NCC) is a leading cause of seizures and epilepsy worldwide. Its clinical manifestations are varied, non specific and pleomorphic, depending on multiple factors. Since NCC mimic large number of neurological disorders, it is important that clinicians should be familiar with these rare presentations to avoid delay in diagnosis and management. We herein describe an unusual case of multiple NCC’s involving entire cortex with only cognitive and behavioural manifestations and review pertinent literature.

Cite this paper
nullR. Verma, K. Anand, M. Chandra, N. Prakash and A. Sachdeva, "Neurocysticercosis Association with Cognitive and Aberrant Behavioural Symptoms: A Case Report and Review," Journal of Behavioral and Brain Science, Vol. 1 No. 4, 2011, pp. 229-233. doi: 10.4236/jbbs.2011.14029.
References
[1]   O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., V. C. Tsang, T. E. Nash, O. M. Takayanagui, et al., “Proposed Diagnostic Criteria for Neurocysticercosis,” Neurology, Vol. 57, No. 2, 2001, pp. 177-183.

[2]   H. H. Garcia and O. H. Del Brutto, “Neurocysticercosis: Updated Concepts about an Old Disease,” Lancet Neurology, Vol. 4, No. 10, 2005, pp. 653-661. doi:10.1016/S1474-4422(05)70194-0

[3]   M. F. Folstein, S. E. Folstein and P. R. McHugh, ““Mini-Mental State”: A Practical Method for Grading the Cognitive State of Patients for the Clinician,” Journal of Psychiatric Research, Vol. 12, No. 3, 1975, pp. 189- 198. doi:10.1016/0022-3956(75)90026-6

[4]   J. C. Morris, “The Clinical Dementia Rating (CDR): Cur- rent Version and Scoring Rules,” Neurology, Vol. 43, 1993, pp. 2412-2414.

[5]   M. Hamilton, “A Rating Scale for Depression,” Journal of Neurology, Neurosurgery and Psychiatry, Vol. 23, No. 1, 1960, pp. 56-62. doi:10.1136/jnnp.23.1.56

[6]   O. P. Almeida and N. T. Lautenschlager, “Dementia Associated with Infectious Diseases,” International Psychogeriatric, Vol. 17, Suppl. 1, 2005, pp. 65-77. doi:10.1017/S104161020500195X

[7]   A. Carpio, “Neurocysticercosis: An Update,” The Lancet Infectious Diseases, Vol. 2, No. 12, 2002, pp. 751-762. doi:10.1016/S1473-3099(02)00454-1

[8]   S. Sinha and B. S. Sharma, “Neurocysticercosis: A Review of Current Status and Management,” Journal of Clinical Neuroscience, Vol. 16, No. 7, 2009, pp. 867-876. doi:10.1016/j.jocn.2008.10.030

[9]   N. Arriada-Mendicoa, M. A. Celis-López, J. Higuera- Calleja and T. Corona-Vázquez, “Imaging Features of Se- llar Cysticercosis,” American Journal of Neuroradiology, Vol. 24, No. 7, 2003, pp. 1386-1389.

[10]   V. Rajshekhar, R. P. Haran, G. S. Prakash and M. J. Chandy, “Differentiating Solitary Small Cysticercus Granulomas and Tuberculomas in Patients with Epilepsy. Clinical and Computerized Tomographic Criteria,” Journal of Neurosurgery, Vol. 78, No. 3, 1993, pp. 402-407. doi:10.3171/jns.1993.78.3.0402

[11]   O. V. Forlenza, A. H. Filho, J. P. Nobrega, L. dos Ramos Machado, N. G. de Barros, C. H. de Camargo, et al., “Psychiatric Manifestations of Neurocysticercosis: A Study of 38 Patients from a Neurology Clinic in Brazil,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 62, No. 6, 1997, pp. 612-616. doi:10.1136/jnnp.62.6.612

[12]   F. Cendes and M. Ferreira, “Manifestacoes Psiquiatricas da Neurocisticercose,” Jornal Brasileiro de Psiquiatria, Vol. 35, No. 2, 1986, pp. 101-106.

[13]   J. Sotelo, V. Geurrero and F. Rubio, “Neurocysticercosis: A New Classification Based on Active and Inactive Forms,” Archives of Internal Medicine, Vol. 145, No. 3, 1985, pp. 442-445. doi:10.1001/archinte.145.3.442

[14]   L. Loo and A. Braude, “Cerebral Cysticercosis in San Diego: A Review of 23 Cases and a Review of the Litera- Ture,” Medicine, Vol. 61, No. 6, 1982, pp. 341-359.

[15]   G. F. McCormick, C. S. Zee and J. Heiden, “Cysticerco- sis Cerebri: Review of 127 Cases,” Archives of Neurology, Vol. 39, No. 9, 1982, pp. 534-539.

[16]   J. S. Grisolia and W. C. Wiederholt, “CNS Cysticercosis,” Archives of Neurology, Vol. 39, No. 9, 1982, pp. 540-544.

[17]   D. Scharf, “Neurocysticercosis: Two Hundred Thirty- Eight Cases from a California Hospital,” Archives of Ne- urology, Vol. 45, No. 7, 1988, pp. 777-780.

[18]   N. Wadia, S. Desai and M. Bhatt, “Disseminated Cysticercosis: New Observations, Including CT Scan Findings and Experience with Treatment by Praziquantel,” Brain, Vol. 111, No. 3, 1988, pp. 597-614. doi:10.1093/brain/111.3.597

[19]   F. Barinagarrementeria and O. H. Del Brutto, “Neurocysticercosis and Pure Motor Hemiparesis,” Stroke, Vol. 19, No. 9, 1988, pp. 1156-1158. doi:10.1161/01.STR.19.9.1156

[20]   B. N. Mishra and S. P. Swain, “Psychiatric Morbidity Following Neurocysticercosis,” Indian Journal of Psychiatry, Vol. 46, No. 3, 2004, pp. 268-269.

[21]   A. Verma, N. N. Singh and S. Misra, “Transitory Alexia without Agraphia: A Disconnection Syndrome Due to Neurocysticercosis,” Neurology India, Vol. 52, No. 3, 2004, pp. 378-379.

[22]   D. K. Pal, A. Carpio and J. W. A. S. Sander, “Neurocys- ticercosis and Epilepsy in Developing Countries,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 68, No. 2, 2000, pp. 137-143. doi:10.1136/jnnp.68.2.137

[23]   H. B. F. Dixon and F. M. Lipscornbe, “Cysticercosis: An Analysis and Follow-Up of 450 Cases,” Medical Re- search Council Special Report Series No. 299, Her Ma- jesty’s Stationery Office, London, 1961.

[24]   D. Ciampi de Andrade, C. L. Rodrigues, R. Abraham, L. H. Castro, J. A. Livramento, L. R. Machado, et al., “Cognitive Impairment and Dementia in Neurocysticercosis: A Cross-Sectional Controlled Study,” Neurology, Vol. 74, No. 16, 2010, pp. 1288-1295. doi:10.1212/WNL.0b013e3181d9eda6

[25]   A. Rosselli, M. Rosselli, A. Ardila and B. Penagos, “Se- vere Dementia Associated with Neurocysticercosis,” In- ternational Journal of Neuroscience, Vol. 41, No. 1-2, 1988, pp. 87-95.

[26]   M. Diagana, M. E. Cruz, A. Tabo, I. Cruz, M. Dumas and P. M. Preux, “Cognitive Disorders in an Andean Community Located in a Cysticercosis Endemic Zone of Ecuador,” Medecine Tropicale, Vol. 65, No. 4, 2005, pp. 343-345.

[27]   S. Jha and M. K. Ansari, “Dementia as the Presenting Manifestation of Neurocysticercosis: A Report of Two Patients,” Neurology Asia, Vol. 15, No. 1, 2010, pp. 83- 87.

[28]   A. Biswas, A. Prasad and K. S. Anand, “Cysticercal De- Mentia,” Journal of Association of Physicians of India, Vol. 46, No. 6, 1998, p. 569.

[29]   R. M. Hoek, R. E. van Kesteren, A. B. Smit, M. de JongBrink and W. P. Geraerts, “Altered Gene Expression in the Host Brain Caused by a Trematode Parasite: Neuropeptide Genes Are Preferentially Affected during Parasitosis,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, No. 25, 1997, pp. 14072-14076. doi:10.1073/pnas.94.25.14072

[30]   A. Vyas, S. K. Kim, N. Giacomini, J. C. Boothroyd and R. M. Sapolsky, “Behavioral Changes Induced by Toxoplas- ma Infection of Rodents Are Highly Specific to Aversion of Cat Odors,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 15, 2007, pp. 6442-6447. doi:10.1073/pnas.0608310104

[31]   M. M. Bianchin, T. R. Velasco, O. M. Takayanagui and A. C. Sakamoto, “Neurocysticercosis, Mesial Temporal Lobe Epilepsy, and Hippocampal Sclerosis: An Association Largely Ignored,” Lancet Neurology, Vol. 5, No. 1, 2006, pp. 20-21. doi:10.1016/S1474-4422(05)70269-6

[32]   J. Ramirez-Bermudez, J. Higuera, A. L. Sosa, E. Lopez- Meza, M. Lopez-Gomez and T. Corona, “Is Dementia Reversible in Patients with Neurocysticercosis?” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 76, No. 8, 2005, pp.1164-1166. doi:10.1136/jnnp.2004.052126

 
 
Top